Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

IRB

Showing results (581-590 of 778) with videos related to

Pageof 78
Sort By:
IRB|May 1, 1996
Who understands? II: A survey of 27 words, phrases, or symbols used in proposed clinical research consent formsWilliam C Waggoner, Barbara B Sherman
IRB|August 1, 1981
Insertion of the total artificial heartE J Eichwald, F R Woolley, B Cole, et al.
IRB|November 1, 1981
The ethics of research on court-ordered evaluation and therapy for exhibitionismWilliam D Murphy, David C Thomasma
IRB|November 1, 1981
What should subjects be told about withdrawing from a protocol?Robert J Levine
IRB|May 1, 1982
IRB intervention in the consent processJohn A Robertson
IRB|May 1, 1982
Why HHS should reconsider its proposed exemption for social policy experimentsMorris B Abram,
IRB|May 1, 1982
Students, grades, and informed consent: case studyHarold F Gamble
IRB|December 1, 1981
An overview of FDA, IRBs and regulationsJohn C Petricciani
IRB|December 1, 1981
Can (or should) the IRB assume the FDA's functions at early stages of the IND process?Robert J Levine
IRB|October 20, 2001
Selective review of external adverse events: one IRB's response to the avalanche of IND safety reportsBruce Gordon, Ernest Prentice
Pageof 78

Showing results (581-590 of 778) with videos related to

Sort By:
Pageof 78
IRB|May 1, 1996
Who understands? II: A survey of 27 words, phrases, or symbols used in proposed clinical research consent formsWilliam C Waggoner, Barbara B Sherman
IRB|August 1, 1981
Insertion of the total artificial heartE J Eichwald, F R Woolley, B Cole, et al.
IRB|November 1, 1981
The ethics of research on court-ordered evaluation and therapy for exhibitionismWilliam D Murphy, David C Thomasma
IRB|November 1, 1981
What should subjects be told about withdrawing from a protocol?Robert J Levine
IRB|May 1, 1982
IRB intervention in the consent processJohn A Robertson
IRB|May 1, 1982
Why HHS should reconsider its proposed exemption for social policy experimentsMorris B Abram,
IRB|May 1, 1982
Students, grades, and informed consent: case studyHarold F Gamble
IRB|December 1, 1981
An overview of FDA, IRBs and regulationsJohn C Petricciani
IRB|December 1, 1981
Can (or should) the IRB assume the FDA's functions at early stages of the IND process?Robert J Levine
IRB|October 20, 2001
Selective review of external adverse events: one IRB's response to the avalanche of IND safety reportsBruce Gordon, Ernest Prentice
Pageof 78